Skandinaviska Enskilda Banken (SEB)
KRYS icon

Skandinaviska Enskilda Banken (SEB)’s Krystal Biotech KRYS Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-46,732
Closed -$11.5M – 460
2025
Q4 		$11.5M Sell
46,732
-13,246
-22% -$2.79M 0.05% 253
2025
Q3 		$10.6M Hold
59,978
– – 0.04% 269
2025
Q2 		$8.24M Hold
59,978
– – 0.04% 330
2025
Q1 		$10.8M Sell
59,978
-29,069
-33% -$4.89M 0.05% 265
2024
Q4 		$14.2M Sell
89,047
-37,035
-29% -$6.57M 0.06% 220
2024
Q3 		$23M Sell
126,082
-65,433
-34% -$12.6M 0.11% 162
2024
Q2 		$35.2M Sell
191,515
-26,232
-12% -$4.4M 0.17% 105
2024
Q1 		$38.7M Sell
217,747
-26,314
-11% -$3.66M 0.19% 96
2023
Q4 		$30.3M Hold
244,061
– – 0.18% 115
2023
Q3 		$28.3M Sell
244,061
-41,799
-15% -$5.1M 0.19% 104
2023
Q2 		$33.6M Sell
285,860
-158
-0.1% -$16.1K 0.22% 98
2023
Q1 		$22.9M Sell
286,018
-1,523
-0.5% -$120K 0.16% 138
2022
Q4 		$22.8M Sell
287,541
-10,069
-3% -$747K 0.17% 140
2022
Q3 		$20.7M Hold
297,610
– – 0.16% 128
2022
Q2 		$19.5M Buy
297,610
+88,899
+43% +$5.53M 0.14% 148
2022
Q1 		$13.9M Sell
208,711
-115
-0.1% -$7.18K 0.08% 218
2021
Q4 		$14.7M Buy
208,826
+75,825
+57% +$4.41M 0.08% 228
2021
Q3 		$6.94M Buy
133,001
+6,709
+5% +$397K 0.04% 352
2021
Q2 		$8.59M Buy
126,292
+112,671
+827% +$7.86M 0.05% 311
2021
Q1 		$1.05M Buy
+13,621
New +$990K 0.01% 817

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s KRYS Position: Q1 2026 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Krystal Biotech (KRYS) in Q1 2026, closing a stake of 46,732 shares — an estimated $11.5M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in KRYS in Q1 2021 and held it in 20 quarters. The position peaked at $38.7M in Q1 2024. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Krystal Biotech position as of Q1 2026 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 46,732 Krystal Biotech shares in Q1 2026, an estimated $11.5M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Krystal Biotech in Q1 2021 and held it in 20 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Krystal Biotech position peaked at $38.7M in Q1 2024.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.